Literature DB >> 8722686

Biologic and clinical implications of marrow culture studies in the myelodysplastic syndromes.

P L Greenberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8722686

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  4 in total

1.  Transplantation of a myelodysplastic syndrome by a long-term repopulating hematopoietic cell.

Authors:  Yang Jo Chung; Chul Won Choi; Christopher Slape; Terry Fry; Peter D Aplan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-03       Impact factor: 11.205

2.  Haploinsufficiency of Apc leads to ineffective hematopoiesis.

Authors:  Jianghong Wang; Anthony A Fernald; John Anastasi; Michelle M Le Beau; Zhijian Qian
Journal:  Blood       Date:  2010-01-11       Impact factor: 22.113

3.  A Phase II intra-patient dose-escalation trial of weight-based darbepoetin alfa with or without granulocyte-colony stimulating factor in myelodysplastic syndromes.

Authors:  Jason Gotlib; Philip Lavori; Sylvia Quesada; Richard S Stein; Shahin Shahnia; Peter L Greenberg
Journal:  Am J Hematol       Date:  2009-01       Impact factor: 10.047

4.  Colony-forming unit cell (CFU-C) assays at diagnosis: CFU-G/M cluster predicts overall survival in myelodysplastic syndrome patients independently of IPSS-R.

Authors:  Bing Li; Jinqin Liu; Shiqiang Qu; Robert Peter Gale; Zhen Song; Ruixian Xing; Junxia Liu; Yansong Ren; Zefeng Xu; Tiejun Qin; Yue Zhang; Liwei Fang; Hongli Zhang; Lijuan Pan; Naibo Hu; Wenyu Cai; Peihong Zhang; Gang Huang; Zhijian Xiao
Journal:  Oncotarget       Date:  2016-10-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.